Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does HYALURONIDASE Cause Condition aggravated? 313 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 313 reports of Condition aggravated have been filed in association with HYALURONIDASE (Phesgo). This represents 28.3% of all adverse event reports for HYALURONIDASE.

313
Reports of Condition aggravated with HYALURONIDASE
28.3%
of all HYALURONIDASE reports
210
Deaths
293
Hospitalizations

How Dangerous Is Condition aggravated From HYALURONIDASE?

Of the 313 reports, 210 (67.1%) resulted in death, 293 (93.6%) required hospitalization, and 268 (85.6%) were considered life-threatening.

Is Condition aggravated Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for HYALURONIDASE. However, 313 reports have been filed with the FAERS database.

What Other Side Effects Does HYALURONIDASE Cause?

Fatigue (375) Alopecia (358) Abdominal discomfort (355) Arthralgia (349) Diarrhoea (330) Headache (328) Hypertension (325) Blood cholesterol increased (320) Arthropathy (318) Off label use (315)

What Other Drugs Cause Condition aggravated?

TOFACITINIB (16,925) INFLIXIMAB (16,616) DUPILUMAB (16,459) ETANERCEPT (15,897) METHOTREXATE (14,938) ADALIMUMAB (13,527) PREDNISONE (10,751) INFLIXIMAB-DYYB (10,275) HYDROXYCHLOROQUINE (8,848) RITUXIMAB (8,627)

Which HYALURONIDASE Alternatives Have Lower Condition aggravated Risk?

HYALURONIDASE vs HYALURONIDASE-OCSQ\OCRELIZUMAB HYALURONIDASE vs HYALURONIDASE \RITUXIMAB HYALURONIDASE vs HYALURONIDASE-ZZXF\PERTUZUMAB\TRASTUZUMAB HYALURONIDASE vs HYDRALAZINE HYALURONIDASE vs HYDRALAZINE\ISOSORBIDE DINITRATE

Related Pages

HYALURONIDASE Full Profile All Condition aggravated Reports All Drugs Causing Condition aggravated HYALURONIDASE Demographics